VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
+34.75%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$487M
AUM Growth
+$487M
(+205%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
72.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Praxis Precision Medicines
PRAX
|
$162M |
| 2 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$109M |
| 3 |
KRON
Kronos Bio
KRON
|
$82.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Praxis Precision Medicines
PRAX
$958M
| $162M | 33.19% | +2,939,329 | New | +$162M |
|
|
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $109M | 22.43% | +2,747,074 | New | +$109M |
|
|
KRON
3
DELISTED
Kronos Bio
KRON
| $82.6M | 16.95% | +2,765,314 | New | +$82.6M |
|
4
Dyne Therapeutics
DYN
$1.92B
| $62.2M | 12.76% | 2,960,046 | – | – |
|
5
Allogene Therapeutics
ALLO
$251M
| $45.4M | 9.32% | 1,798,163 | – | – |
|
|
OYST
6
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $14.7M | 3.01% | 778,468 | – | – |
|
7
Q32 Bio
QTTB
$20.9M
| $8.7M | 1.79% | 770,845 | – | – |
|
8
Assembly Biosciences
ASMB
$190M
| $2.72M | 0.56% | 450,000 | – | – |
|